Engy Habashy, MD, discusses key takeaways from the 2025 AUA GSM guideline, including the role of androgens and hormonal therapies in managing genitourinary syndrome of menopause.
Related to this article
These FAQs outline key recommendations and practical takeaways from the AUA/SUFU/AUGS Genitourinary Syndrome of Menopause guideline.
Advertisement
Advertisement
Trending on Urology Times
1
Adding darolutamide to ADT and radiation improves MFS in very high-risk localized prostate cancer
2
Gedatolisib plus darolutamide shows preliminary activity in mCRPC
3
ESMO On Location 2026 Day 1
4
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
5